Form 8-K - Current report:
SEC Accession No. 0001087294-13-000013
Filing Date
2013-10-31
Accepted
2013-10-30 18:45:17
Documents
3
Period of Report
2013-10-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8kpernixtherapeutics10242.htm 8-K 28351
2 PRESS RELEASE DATED OCTOBER 28, 2013 pernixpressrelease-01.htm EX-99.1 8847
3 cumberlandpicture.jpg GRAPHIC 35104
  Complete submission text file 0001087294-13-000013.txt   86706
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 131180406
SIC: 2834 Pharmaceutical Preparations